Cost-effectiveness and budget impact of lung cancer immunotherapy in South America: strategies to improve access. [electronic resource]
- Immunotherapy 08 2018
- 887-897 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1750-7448
10.2217/imt-2017-0183 doi
Antineoplastic Agents, Immunological--economics Carcinoma, Non-Small-Cell Lung--drug therapy Cost-Benefit Analysis Economics, Pharmaceutical Health Services Accessibility--economics Humans Immunotherapy--economics Lung Neoplasms--drug therapy South America